Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dosell is a Swedish digital health and medtech company focused on safer medication management in the home and elderly care settings. Its core product is a patented medication robot that automatically dispenses dose-packed tablets at scheduled times, reminds patients to take their medicines, and alerts caregivers or healthcare professionals when doses are missed. The business operates as a subsidiary of iZafe Group and is part of a broader digital medication-management offering that includes connected software and remote-care capabilities. Dosell sells to municipalities, healthcare providers, partners, and private users, with commercialization in Sweden and expansion through partners in other Nordic and European markets. The company is commercial-stage and positions itself around improving adherence, reducing medication errors, and lowering healthcare utilization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dosell.